Browsing by Author "Yanez Arteta, M"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Apolipoprotein E binding drives structural and compositional rearrangement of mRNA-containing lipid nanoparticles
    (American Chemical Society (ACS), 2021-03-23) Sebastiani, F; Yanez Arteta, M; Lerche, M; Porcar, L; Lang, C; Bragg, RA; Elmore, CS; Krishnamurthy, VR; Russell, RA; Darwish, TA; Pichler, H; Waldie, S; Moulin, M; Haertlein, M; Forsyth, VT; Lindfors, L; Cárdenas, M
    Emerging therapeutic treatments based on the production of proteins by delivering mRNA have become increasingly important in recent times. While lipid nanoparticles (LNPs) are approved vehicles for small interfering RNA delivery, there are still challenges to use this formulation for mRNA delivery. LNPs are typically a mixture of a cationic lipid, distearoylphosphatidylcholine (DSPC), cholesterol, and a PEG-lipid. The structural characterization of mRNA-containing LNPs (mRNA-LNPs) is crucial for a full understanding of the way in which they function, but this information alone is not enough to predict their fate upon entering the bloodstream. The biodistribution and cellular uptake of LNPs are affected by their surface composition as well as by the extracellular proteins present at the site of LNP administration, e.g., apolipoproteinE (ApoE). ApoE, being responsible for fat transport in the body, plays a key role in the LNP's plasma circulation time. In this work, we use small-angle neutron scattering, together with selective lipid, cholesterol, and solvent deuteration, to elucidate the structure of the LNP and the distribution of the lipid components in the absence and the presence of ApoE. While DSPC and cholesterol are found to be enriched at the surface of the LNPs in buffer, binding of ApoE induces a redistribution of the lipids at the shell and the core, which also impacts the LNP internal structure, causing release of mRNA. The rearrangement of LNP components upon ApoE incubation is discussed in terms of potential relevance to LNP endosomal escape. © 2021 American Chemical Society. Open Access. This publication is licensed under CC-BY 4.0.
  • Thumbnail Image
    Item
    Evolution of the structure of lipid nanoparticles for nucleic acid delivery: from in situ studies of formulation to colloidal stability
    (Elsevier, 2024-04-15) Gilbert, J; Sebastiani, F; Yanez Arteta, M; Terry, A; Fornell, A; Russell, RA; Mahmoudi, N; Nylander, T
    The development of lipid nanoparticle (LNP) based therapeutics for delivery of RNA has triggered the advance of new strategies for formulation, such as high throughput microfluidics for precise mixing of components into well-defined particles. In this study, we have characterised the structure of LNPs throughout the formulation process using in situ small angle x-ray scattering in the microfluidic chip, then by sampling in the subsequent dialysis process. The final formulation was investigated with small angle x-ray (SAXS) and neutron (SANS) scattering, dynamic light scattering (DLS) and cryo-TEM. The effect on structure was investigated for LNPs with a benchmark lipid composition and containing different cargos: calf thymus DNA (DNA) and two model mRNAs, polyadenylic acid (polyA) and polyuridylic acid (polyU). The LNP structure evolved during mixing in the microfluidic channel, however was only fully developed during the dialysis. The colloidal stability of the final formulation was affected by the type of incorporated nucleic acids (NAs) and decreased with the degree of base-pairing, as polyU induced extensive particle aggregation. The main NA LNP peak in the SAXS data for the final formulation were similar, with the repeat distance increasing from polyU